Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Infinium Pharmachem Limited (NSE: INFINIUM), ISIN INE0MRE01011 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
INFINIUM last traded at ₹267.25 (-2.84%), with a 52-week range of ₹189.40 to ₹324.50 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 64.91%, FIIs 0.00%, DIIs 0.23%, mutual funds 0.00%.
EquiSense Score (ECS): 70/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.